Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
21.3M
-
Shares change
-
+1.22M
-
Total reported value, excl. options
-
$920M
-
Value change
-
+$53.4M
-
Number of buys
-
73
-
Number of sells
-
-32
-
Price
-
$43.20
Significant Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q2 2020
112 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2020.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.3M shares
of 45.1M outstanding shares and own 47.19% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2.33M shares), BlackRock Inc. (2.31M shares), Sofinnova Investments, Inc. (2.19M shares), Cormorant Asset Management, LP (1.57M shares), FMR LLC (1.31M shares), VANGUARD GROUP INC (1.24M shares), STATE STREET CORP (956K shares), ALLIANCEBERNSTEIN L.P. (887K shares), LOOMIS SAYLES & CO L P (774K shares), and Artisan Partners Limited Partnership (626K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.